BioCentury
ARTICLE | Company News

OctoPlus deal

September 20, 2010 7:00 AM UTC

OctoPlus and an undisclosed pharmaceutical company added the feasibility analysis of a controlled-release version of an undisclosed compound from the pharma to an earlier deal. OctoPlus was already co...